1412418-18-8Relevant articles and documents
TREATMENT OF DRY EYE
-
Page/Page column 51, (2014/02/16)
The present disclosure provides a method of treating dry eye by inhibition of Bruton's tyrosine kinase (hereinafter "BTK") inhibitors, pharmaceutical formulations comprising the same, and processes for preparing such compounds.
KINASE INHIBITORS
-
Paragraph 0400-0402, (2014/11/11)
Provided herein are kinase inhibiting compounds and methods of using the same.
TYROSINE KINASE INHIBITORS
-
, (2012/12/13)
The present disclosure provides compounds and pharmaceutically acceptable salts thereof that are tyrosine kinase inhibitors, in particular BLK, BMX, EGFR, HER2, HER4, ITK, TEC, BTK, and TXK and are therefore useful for the treatment of diseases treatable by inhibition of tyrosine kinases such as cancer and inflammatory diseases such as arthritis, and the like. Also provided are pharmaceutical compositions containing such compounds and pharmaceutically acceptable salts thereof and processes for preparing such compounds and pharmaceutically acceptable salts thereof.